← All trials
NCT06180889
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 20, 2023
- Primary completion
- Dec 15, 2025
- Completion date
- Apr 15, 2026
- First posted
- Dec 26, 2023
- Last posted
- Dec 29, 2023
- Enrollment
- 240
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Alphamab Co., Ltd.Lead sponsor
- Tsinghua UniversityOverall official - principal investigator
- Chongqing Medical UniversityOverall official - principal investigator
- Fujian Medical UniversityOverall official - principal investigator
- Fudan UniversityOverall official - principal investigator
- Hebei UniversityOverall official - principal investigator
- Zhejiang UniversityOverall official - principal investigator
- LanZhou UniversityOverall official - principal investigator
- Jiao Tong UniversityOverall official - principal investigator
- Tongji UniversityOverall official - principal investigator
- Jiao Tong UniversityOverall official - principal investigator
- Guizhou Medical UniversityOverall official - principal investigator
- Nanchang UniversityOverall official - principal investigator
- The Third Hospital of ChangshaOverall official - principal investigator
- Tongji UniversityOverall official - principal investigator
- Sichuan UniversityOverall official - principal investigator
- Qingdao UniversityOverall official - principal investigator
- Southeast UniversityOverall official - principal investigator
- The People's Hospital of GaozhouOfficial
- Qingdao UniversityOfficial
- Tongji UniversityOfficial
- Tongji UniversityOfficial
- Sichuan UniversityOfficial
- Zhejiang UniversityOfficial
- Nanchang UniversityOfficial
- Southeast UniversityOfficial
- LanZhou UniversityOfficial
- Tsinghua UniversityOfficial
- Hebei UniversityOfficial
- Fujian Medical UniversityOfficial
- Chongqing Medical UniversityOfficial
- The Third Hospital of ChangshaOfficial
- Jiao Tong UniversityOfficial
- Jiao Tong UniversityOfficial
- Fudan UniversityOfficial
- Guizhou Medical UniversityOfficial
- Huazhong University of Science and TechnologyOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.